Insight

Bouthaina Dabaja: Target nomenclature for lymphoma trials

Collage photo of Bouthaina Dabaja and Omran Saifi

Oct 6, 2024, 12:47

Bouthaina Dabaja: Target nomenclature for lymphoma trials

Bouthaina Dabaja, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X about a recent paper by Omran Saifi et al. published in The Lancet Hematology.

“Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups”

Authors: Omran Saifi, Chelsea Pinnix, Leslie Ballas, David Hodgson, Bradford Hoppe et al.

“A superb document by Omran Saifi, Bradford Hoppe on RT target nomenclature for lymphoma trials.”

Source: Bouthaina Dabaja/X

Bouthaina Dabaja Bradford Hoppe cancer Chelsea Pinnix David Hodgson Leslie Ballas lymphoma MD Anderson Cancer Center Omran Saifi OncoDaily Oncology The Lancet Hematology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage